about
Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expressionHemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogeninFull-breadth analysis of CD8+ T-cell responses in acute hepatitis C virus infection and early therapy.Human Immunodeficiency Virus Type 1-Hepatitis C Virus Coinfection: Intraindividual Comparison of Cellular Immune Responses against Two Persistent VirusesComprehensive Analysis of CD8+-T-Cell Responses against Hepatitis C Virus Reveals Multiple Unpredicted SpecificitiesViral RNA mutations are region specific and increased by ribavirin in a full-length hepatitis C virus replication system.Broad Specificity of Virus-Specific CD4+ T-Helper-Cell Responses in Resolved Hepatitis C Virus InfectionImpaired Hepatitis C Virus-Specific T Cell Responses and Recurrent Hepatitis C Virus in HIV CoinfectionOutcomes and Treatment of Acute Hepatitis C Virus Infection in a United States PopulationEx vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramersImmunologic evidence for lack of heterologous protection following resolution of HCV in patients with non genotype 1 infectionViral Sequence Evolution in Acute Hepatitis C Virus InfectionCD8 Epitope Escape and Reversion in Acute HCV InfectionHigh Level of PD-1 Expression on Hepatitis C Virus (HCV)-Specific CD8+ and CD4+ T Cells during Acute HCV Infection, Irrespective of Clinical OutcomeNaturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naïve patientsImproving the Diagnosis of Acute Hepatitis C Virus Infection with Expanded Viral Load CriteriaRate of Sustained Virologic Response in Relation to Baseline Hepatitis C Virus (HCV) RNA Level and Rapid Virologic Clearance in Persons with Acute HCV InfectionPeginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected personsProtein kinase R modulates c-Fos and c-Jun signaling to promote proliferation of hepatocellular carcinoma with hepatitis C virus infectionHuman immunodeficiency virus and liver disease forum 2010: conference proceedingsAn IL28B genotype-based clinical prediction model for treatment of chronic hepatitis CShear-wave elastography for the estimation of liver fibrosis in chronic liver disease: determining accuracy and ideal site for measurementGenome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts.Predictors of antiretroviral-related hepatotoxicity in the adult AIDS Clinical Trial Group (1989-1999).Viral kinetics in hepatitis C or hepatitis C/human immunodeficiency virus-infected patientsAntigen-specific immune responses and liver histology in HIV and hepatitis C coinfection.Relationships between cellular immune responses and treatment outcomes with interferon and ribavirin in HIV/hepatitis C virus co-infection.Viral factors associated with cytokine expression during HCV/HIV co-infection.Reduction of insulin resistance with effective clearance of hepatitis C infection: results from the HALT-C trialNonalcoholic steatohepatitis is associated with an atherogenic lipoprotein subfraction profile.Hepatitis C virus regulates transforming growth factor beta1 production through the generation of reactive oxygen species in a nuclear factor kappaB-dependent manner.Heat stroke leading to acute liver injury & failure: A case series from the Acute Liver Failure Study GroupEffects of HCV treatment on cytokine expression during HCV/HIV coinfection.Ceestatin, a novel small molecule inhibitor of hepatitis C virus replication, inhibits 3-hydroxy-3-methylglutaryl-coenzyme A synthase.Influence of body mass index on outcome of pediatric chronic hepatitis C virus infection.IL28B alleles exert an additive dose effect when applied to HCV-HIV coinfected persons undergoing peginterferon and ribavirin therapySerum vitamin D levels are not predictive of the progression of chronic liver disease in hepatitis C patients with advanced fibrosis.ARF1 and GBF1 generate a PI4P-enriched environment supportive of hepatitis C virus replication.Sustained long-term antiviral maintenance therapy in HCV/HIV-coinfected patients (SLAM-C)Spontaneous control of HCV is associated with expression of HLA-B 57 and preservation of targeted epitopes.
P50
Q24316099-DA351A13-F815-4199-986A-3CF72AF7C632Q24321923-F6DE2556-BA83-4167-A3DB-1DB8283D2242Q27472170-E2152A01-BD7E-487D-9BBF-8FEB39B5AC55Q27472844-A90B1A07-3077-46D2-AA22-B251E6319CBAQ27472881-ACD37B70-3F3A-44F1-8DF4-F3BEED4DE523Q27472893-28B1A158-13AA-4FD4-8AC6-F21F7FF93D4DQ27472915-C1A4BDE4-39A1-4E43-A51E-A2FAEB107447Q27477797-0302C5A3-BD8C-4621-A2F0-1E5381EDFAAEQ27478177-687381BB-CD68-4487-A4B5-649407DF7EC4Q27480953-6978F8A5-7BBD-47D7-A5EC-C68295B31127Q27481055-FEB8FBB2-7B0F-4F40-BB7D-C36E15D5D05CQ27484985-957EED82-BD01-4A1C-81D8-8D3A2E7E90C8Q27485189-97FB1961-1A87-42BF-B601-3D88127FACBFQ27485454-5009FE7B-64C8-4D11-82FE-B9FE703001C7Q27487949-83F4CBCC-1462-45C3-86EC-A48832B6BAB2Q27489594-62D864DB-79C7-4384-8C9C-846EAF0D5E36Q27490171-9A73E416-E10D-47E6-8863-835B58616BA3Q28274676-4B5BF05E-B75C-4CBD-A32D-B331F1F9A6ADQ28385007-50FABC0F-3A52-4AD4-B05A-845CD531462BQ28674930-D1222B54-6E33-4733-B9CA-E01F5467A976Q28742764-06734DCE-8C60-4180-8456-81DE5ED2EF09Q30389962-ED1BA91A-EF27-4E67-8248-771AB065A0AFQ30590832-98B327CC-513A-4A7B-9897-E185CC545414Q33372615-1925530A-4FD0-40CB-A8C2-5AD05C25E2BFQ33675362-D2AE5A2D-7ECA-4A8D-873C-1FA46BA42A82Q33730915-5159C5CC-00F1-4084-AE09-CDB68FD7D907Q33767267-5AA5D376-BEF8-485C-BA06-A94C30E63A95Q33790563-565A35CE-5DA8-4102-85BF-087F1245E028Q33798375-2CB4430D-5F45-4429-90FA-F78BF72B6998Q33820345-AC327CE2-4C0C-4DCB-BB19-EF2557BB0911Q33905849-7F0D4700-A455-4A18-9168-79EFF7D274EFQ33917962-A174575B-239D-4879-9ED8-DCCA1DF2298AQ33961483-D7E5E0D4-B05F-4651-AA6F-13413530AA90Q33972367-409DCE47-1F1D-4190-838D-12AC9BE12EB6Q34023077-C53EE38C-A8C8-4A2D-B3B7-B89B8AB3F53BQ34049322-1A0075AF-A19E-4ACE-B426-FEFAFE3234A0Q34167963-3B46D946-2B2B-4290-9551-75A0A7761A8AQ34168582-8DA8B4A6-5A4F-4838-B506-436F64E70E92Q34474434-3AD029E3-D1D0-49DF-BCEA-E5CBCF2EA220Q34493947-91CA63C2-0D30-4E96-A580-F453E08CAD90
P50
name
Raymond T Chung
@en
type
label
Raymond T Chung
@en
prefLabel
Raymond T Chung
@en